Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Absci Corp

ABSI · Nasdaq · CIK 0001672688 · Healthcare · Biotechnology

INSIDER SIGNAL

58.6 / 100

2 buyers · 2 purchase transaction lines · $349.6K gross purchase

WHY THIS SIGNAL?

Buyer breadthLow
Purchase sizeModerate
RoleStrong
RecencyLow
ConvictionStrong
Score anatomy

Each bar shows the contribution to the current score; the weights and formula stay unchanged.

Cluster+14.0 / 35
Purchase size+13.0 / 25
Role+20.0 / 20
Recency+1.6 / 10
Conviction+10.0 / 10

What is holding the score back?

  • ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
  • ⚠ Purchase activity is becoming less recent
  • ✓ Role scores high · most senior buyer: Director

Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.

US-v1.2 ranks qualifying equity purchases under the current 180-day rules. The score is a research priority, not a return forecast or probability. Backtests have not shown that a higher US score is followed by better returns.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Jonasson ZachariahCFO / CBO
○○○
Szela Mary TDirector
○○●
McClain SeanChief Executive Officer
○○
Pangalos Menelas NDirector
●○
Bedrick ToddSVP, CAO
○
MCGINNIS KAREN KDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 3 additional owner(s) remain in Form 4 evidence.

Purchase breadth & concentration

QUALIFYING BUYERS2
PURCHASE CONCENTRATION57%Largest buyer: Pangalos Menelas N · $200.7K
CLUSTER BUYING · 15D1 insiderPeak activity: 2026-05-13–2026-05-13

Roles in the peak window: Director. Concentration uses priced qualifying P lines only and does not change the saved score.

SIGNAL HISTORY

58.6 / 100

Latest recorded score

↓ -0.1 ptsversus the previous recorded snapshot
  1. 58.9
  2. 58.9
  3. 58.8
  4. 58.7
  5. 58.6

Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.

Recent Form 4 activity

5Purchases
2Sales
40Other Form 4 lines
38SEC filings · 365 days
BUYING2 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER13 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot detected in parsed evidence

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context provides additional background on recent price performance and risk. It does not affect the Insider Signal.

Price performance

1M
+23.3%
3M
-0.5%
6M
+240.9%
12M
+143.1%

Volatility & liquidity

Volatility
101.6%
Beta
2.44
Avg daily value
USD 35.1M

Valuation

Market cap
USD 1.7B
P/E
—

Fundamentals

Profit margin
0.0%
ROE
-60.8%
Industry
Biotechnology

Market data

Price data up to: 2026-10-11 · Price source: OpenBB/yfinance · From SEC filings: Market cap, ROE · Fiscal year ended: 2025-12-31 · Market cap is the shares outstanding stated on the filing cover multiplied by the latest close. Share count date: 2026-07-31 · From Yahoo Finance: Profit margin · Status: PASS

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
37,442,385
Previous report
37,255,325
Avg daily volume
4,977,529
Days to cover
7.5

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-30Szela Mary TPurchase (P)Common Stock12,900USD 11.54USD 148,866SEC filing ↗
2026-05-13Pangalos Menelas NPurchase (P)Common Stock37,453USD 5.36USD 200,748SEC filing ↗
2026-03-12Busch AndreasPurchase (P)Common Stock100,000USD 2.29USD 229,000SEC filing ↗
2026-02-27Pangalos Menelas NPurchase (P)Common Stock75,095USD 2.74USD 205,760SEC filing ↗
2025-12-05VAN HOUTEN FRANSPurchase (P)Common Stock40,000USD 3.72USD 148,800SEC filing ↗
2025-09-22Pangalos Menelas NPurchase (P)Common Stock95,785USD 2.66USD 254,788SEC filing ↗
2025-09-22Bedrick ToddPurchase (P)Common Stock10,000USD 2.70USD 27,000SEC filing ↗
2025-07-28Busch AndreasPurchase (P)Common Stock50,000USD 3.04USD 152,000SEC filing ↗
2024-03-01Green Jeremy; Redmile Group, LLCPurchase (P)Common Stock222,222USD 4.50USD 999,999SEC filing ↗
2022-02-09Korman SarahPurchase (P)Common Stock4,250USD 7.96USD 33,830SEC filing ↗
2022-01-20Bedrick ToddPurchase (P)Common Stock2,000USD 7.50USD 15,000SEC filing ↗
2022-01-19McClain SeanPurchase (P)Common Stock7,155USD 6.92USD 49,513SEC filing ↗
2021-07-26McClain SeanPurchase (P)Common Stock600USD 16.00USD 9,600SEC filing ↗
2021-07-26MCGINNIS KAREN KPurchase (P)Common Stock15,000USD 16.00USD 240,000SEC filing ↗
2021-07-26Korman SarahPurchase (P)Common Stock10,000USD 16.00USD 160,000SEC filing ↗

Form 4 evidence

47 transaction lines in the latest 365-day window; 133 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-12McClain SeanTax withholding (F)Common Stock23,293USD 10.16USD 236,657SEC filing ↗
2026-10-12Jonasson ZachariahTax withholding (F)Common Stock387USD 10.16USD 3,932SEC filing ↗
2026-10-12Bedrick ToddTax withholding (F)Common Stock22,325USD 10.16USD 226,822SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-10-12McClain SeanTax withholding (F)Common Stock23,293USD 10.16USD 236,657SEC filing ↗
2026-10-12Jonasson ZachariahTax withholding (F)Common Stock387USD 10.16USD 3,932SEC filing ↗
2026-10-12Bedrick ToddTax withholding (F)Common Stock22,325USD 10.16USD 226,822SEC filing ↗
2026-08-31Jonasson ZachariahTax withholding (F)Common Stock8,320USD 8.71USD 72,467SEC filing ↗
2026-06-30Szela Mary TPurchase (P)Common Stock12,900USD 11.54USD 148,866SEC filing ↗
2026-06-24McClain SeanTax withholding (F)Common Stock59,896USD 10.08USD 603,752SEC filing ↗
2026-06-04Szela Mary TAward / grant (A)Common Stock8,400USD 0.00USD 0SEC filing ↗
2026-06-04MCGINNIS KAREN KAward / grant (A)Common Stock10,100USD 0.00USD 0SEC filing ↗
2026-06-04VAN HOUTEN FRANSAward / grant (A)Common Stock10,100USD 0.00USD 0SEC filing ↗
2026-06-04Szela Mary TAward / grant (A)Common Stock10,100USD 0.00USD 0SEC filing ↗
2026-06-04Sirosh JosephAward / grant (A)Common Stock10,100USD 0.00USD 0SEC filing ↗
2026-06-04Rabinovitsj Daniel AAward / grant (A)Common Stock10,100USD 0.00USD 0SEC filing ↗
2026-06-04Pangalos Menelas NAward / grant (A)Common Stock10,100USD 0.00USD 0SEC filing ↗
2026-05-31Jonasson ZachariahTax withholding (F)Common Stock8,319USD 6.75USD 56,153SEC filing ↗
2026-05-13Pangalos Menelas NPurchase (P)Common Stock37,453USD 5.36USD 200,748SEC filing ↗
2026-03-12Busch AndreasPurchase (P)Common Stock100,000USD 2.29USD 229,000SEC filing ↗
2026-03-03Walker Shelby J.Tax withholding (F)Common Stock9,825USD 2.80USD 27,510SEC filing ↗
2026-03-03McClain SeanTax withholding (F)Common Stock25,316USD 2.80USD 70,885SEC filing ↗
2026-03-03Jonasson ZachariahTax withholding (F)Common Stock10,848USD 2.80USD 30,374SEC filing ↗
2026-03-03Bedrick ToddTax withholding (F)Common Stock5,282USD 2.80USD 14,790SEC filing ↗
2026-03-03Walker Shelby J.Tax withholding (F)Common Stock9,825USD 2.80USD 27,510SEC filing ↗
2026-03-03McClain SeanTax withholding (F)Common Stock25,316USD 2.80USD 70,885SEC filing ↗
2026-03-03Jonasson ZachariahTax withholding (F)Common Stock10,848USD 2.80USD 30,374SEC filing ↗
2026-03-03Busch AndreasTax withholding (F)Common Stock1,257USD 2.80USD 3,520SEC filing ↗
2026-03-03Bedrick ToddTax withholding (F)Common Stock5,282USD 2.80USD 14,790SEC filing ↗
2026-03-02Walker Shelby J.Award / grant (A)Common Stock90,300USD 0.00USD 0SEC filing ↗
2026-03-02McClain SeanAward / grant (A)Common Stock406,200USD 0.00USD 0SEC filing ↗
2026-03-02Jonasson ZachariahAward / grant (A)Common Stock135,400USD 0.00USD 0SEC filing ↗
2026-03-02Bedrick ToddAward / grant (A)Common Stock49,600USD 0.00USD 0SEC filing ↗
2026-03-02Pangalos Menelas NAward / grant (A)Common Stock5,800USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerABSI
CIK0001672688
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC8731 Services-Commercial Physical & Biological Research
ExchangeNasdaq

Data coverage

Local Form 4 history133 transaction lines from 2021-07-26 to 2026-10-12
20 P purchase lines · 11 S sale lines · 102 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.